Mary Ridge - Comment

Document ID: FDA-2009-N-0247-0146
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 30 2009, at 12:00 AM Eastern Daylight Time
Date Posted: November 13 2009, at 12:00 AM Eastern Standard Time
Comment Start Date: October 5 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: November 6 2009, at 11:59 PM Eastern Standard Time
Tracking Number: 80a4ec35
View Document:

This is comment on Notice

Food and Drug Administration Transparency Task Force; Public Meeting; Request for Comments

View Comment

will the fda protect patients and consumers or will the fda continue to shield drug companies? early drug trials that demonstrate adverse consequences often do not get relayed to future patients while drug manufacturers are allowed to sell compounds to public. Vioxx comes immediately to mind. The first and foremost goal of the FDA should be to protect the safety of the public. Meaning exactly that doctors and patients be given all of the information they need to fully weigh the risks and benefits of a drug.